Preliminary results of a Phase 1 trial with a personalized neoantigen vaccine (ADXS-NEO) in advanced and refractory cancer patients Article

Web of Science: 000496473200865
Open Access

Cited authors

  • Tsai, Frank; Goldman, Jonathan; Matrana, Marc; Sheeri, Sumitra; Heyburn, John; Parsi, Megan; Gutierrez, Andres; Hecht, Joel

Publication date

  • 2019

Published in

International Standard Serial Number (ISSN)

  • 2051-1426


  • 7